OTCMKTS:SBMFF Sino Biopharmaceutical (SBMFF) Stock Forecast, Price & News $0.37 0.00 (0.00%) (As of 09/22/2023 ET) Add Compare Share Share Today's Range$0.37▼$0.3750-Day Range$0.37▼$0.4552-Week Range$0.37▼$0.63VolumeN/AAverage Volume1 shsMarket Capitalization$6.96 billionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestProfileChartCompetitorsFinancialsHeadlinesSEC FilingsShort Interest About Sino Biopharmaceutical (OTCMKTS:SBMFF) StockSino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the People's Republic of China. It operates through three segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The company offers oncology medicines comprising Qingkeshu tablets, Focus V capsules, Annike injection, and Anyue capsules; liver disease medicines, including Tianqing ganmei injection and Runzhong dispersible tablets; and respiratory system medicines, such as Tianqing suchang suspension for inhalation and Tianyun for injection. It also provides surgery/analgesia medicines comprising Debaian cataplasms and Gaisanchun soft capsules; and cardio-cerebral vascular medicines, including Yilunping and Kaina tablets. In addition, the company is involved in the long term investments; and healthcare and hospital business. The company was incorporated in 2000 and is headquartered in Wan Chai, Hong Kong.Read More SBMFF Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SBMFF Stock News HeadlinesSeptember 13, 2023 | jp.reuters.comSino Biopharmaceutical LtdJuly 17, 2023 | investing.comSino Biopharmaceutical Ltd ADR (SBHMY)September 23, 2023 | Behind the Markets (Ad)Jeff Bezos Backs "Drug Smuggler" to Fight Alzheimer'sA small, publicly traded biotech is racing to the discovery of a lifetime: Using a Drug Smuggler to Fight Alzheimer's, Parkinson's and Dementia. This radical treatment is so promising, Biogen, Sanofi and Genentech paid $1 billion to license it. Click here to learn more >>>May 30, 2023 | forbes.comSino-ForestMarch 12, 2023 | finance.yahoo.comSino Biopharmaceutical Limited (1177.HK)March 7, 2023 | msn.comSino Biopharm Wins CFIUS Approval for $161 Million F-Star DealJanuary 26, 2023 | finance.yahoo.cominvoX Pharma and F-star Therapeutics issue Joint StatementNovember 11, 2022 | seekingalpha.comF-star Therapeutics: At A Discount Of >30% To Takeover Offer, With CFIUS Approval On The HorizonSeptember 23, 2023 | Behind the Markets (Ad)BREAKING: Tiny biotech successfully treats blindnessThere's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.August 28, 2022 | finance.yahoo.comChina's CanSinoBIO H1 revenue drops on weaker COVID shot demandJuly 18, 2022 | benzinga.comSino Biopharmaceutical (OTC:SBMFF), Short Interest ReportJuly 18, 2022 | benzinga.comSino Biopharmaceutical (OTC:SBMFF), Analyst Ratings, Price Targets, PredictionsJune 26, 2022 | seekingalpha.comWeek In Review: invoX, A Sino Biopharm Company, To Pay $161 Million To Acquire F-StarJune 23, 2022 | benzinga.comThe Daily Biotech Pulse: F-Star Therapeutics Buyout, Orphan Drug Tag For VBI's Brain Cancer Vaccine, Xenon's Epilepsy Candidate Shows PromiseJune 23, 2022 | marketwatch.comSino Biopharmaceutical Unit to Buy F-star Therapeutics for $161 Million >FSTXJune 23, 2022 | seekingalpha.comSino Biopharma to acquire F-star Therapeutics for $161MJune 23, 2022 | benzinga.comF-star Therapeutics Shares Are Rallying Today - Read WhyJanuary 12, 2022 | nasdaq.comSino Biopharmaceutical Ltd. (SBMFF)August 31, 2021 | markets.businessinsider.comSino Biopharmaceutical is about to announce earnings — here's what Wall Street expectsAugust 5, 2021 | markets.businessinsider.comPenpulimab Monoclonal Antibody (PD-1) Obtains Marketing Approval in ChinaDecember 18, 2020 | wsj.comSino Biopharmaceutical Ltd.October 25, 2020 | msn.comOpinion: Here’s why women fund managers regularly outperform men, based on newer researchAugust 2, 2020 | www.nasdaq.comSino Biopharmaceutical Ltd (SBMFF)May 22, 2020 | finance.yahoo.comShould We Worry About Sino Biopharmaceutical Limited's (HKG:1177) P/E Ratio?April 23, 2020 | finance.yahoo.comChinese cancer drug developer Akeso banks on pharma tie-up in race with rivals amid record-setting Hong Kong IPOApril 22, 2020 | finance.yahoo.comVice Chairwoman of the Board Cheung Ling Cheng Just Bought A Handful Of Shares In Sino Biopharmaceutical Limited (HKG:1177)April 1, 2020 | finance.yahoo.comSino Biopharmaceutical Limited Just Missed EPS By 16%: Here's What Analysts Think Will Happen NextSee More Headlines Receive SBMFF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sino Biopharmaceutical and its competitors with MarketBeat's FREE daily newsletter. Email Address SBMFF Company Calendar Today9/23/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry Private households Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:SBMFF Previous SymbolNASDAQ:SBMFF CUSIPN/A CIK1604982 Webwww.sinobiopharm.com Phone852-2802-9886Fax852-2880-0847Employees26,079Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$3.43 billion Price / Sales2.03 Cash Flow$0.04 per share Price / Cash Flow10.27 Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares18,813,868,000Free FloatN/AMarket Cap$6.96 billion OptionableNot Optionable Beta0.45 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMs. Y. Y. Tse (Age 31)Exec. Chairwoman of the Board Comp: $4.78MMr. Eric S. Y. Tse (Age 27)CEO & Exec. Director Comp: $3.14MMr. Ping Tse (Age 71)Founder & Sr. Exec. Vice Chairman Comp: $5.71MMs. Cheung Ling Cheng (Age 59)Exec. Vice Chairwoman of the Board Comp: $4.03MMs. Mingqin Li (Age 64)Sr. VP & Exec. Director Comp: $163.38kMr. Zhoushan Tian (Age 59)Exec. Director Comp: $246.97kMr. Hsin Tse (Age 53)Sr. VP & Exec. Director Comp: $794.14kMs. Chun Ling Li (Age 51)Chief Financial Officer Sean ChenChief Strategy OfficerOrphanides GeorgeChief Scientific Advisor of invoXMore ExecutivesKey CompetitorsAmplifonOTCMKTS:AMFPFSWEDISH ORPHAN/SOTCMKTS:SWTUYHikma PharmaceuticalsOTCMKTS:HKMPFOrion OyjOTCMKTS:ORINYAspen PharmacareOTCMKTS:APNHYView All Competitors SBMFF Stock - Frequently Asked Questions How have SBMFF shares performed in 2023? Sino Biopharmaceutical's stock was trading at $0.5850 at the start of the year. Since then, SBMFF stock has decreased by 36.8% and is now trading at $0.37. View the best growth stocks for 2023 here. Are investors shorting Sino Biopharmaceutical? Sino Biopharmaceutical saw a increase in short interest in the month of August. As of August 31st, there was short interest totaling 9,174,500 shares, an increase of 131.9% from the August 15th total of 3,955,800 shares. Based on an average trading volume of 2,100 shares, the days-to-cover ratio is presently 4,368.8 days. View Sino Biopharmaceutical's Short Interest. What is Sino Biopharmaceutical's stock symbol? Sino Biopharmaceutical trades on the OTCMKTS under the ticker symbol "SBMFF." How do I buy shares of Sino Biopharmaceutical? Shares of SBMFF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Sino Biopharmaceutical's stock price today? One share of SBMFF stock can currently be purchased for approximately $0.37. How much money does Sino Biopharmaceutical make? Sino Biopharmaceutical (OTCMKTS:SBMFF) has a market capitalization of $6.96 billion and generates $3.43 billion in revenue each year. How many employees does Sino Biopharmaceutical have? The company employs 26,079 workers across the globe. How can I contact Sino Biopharmaceutical? Sino Biopharmaceutical's mailing address is Rm 4109 Office Tower Convention Plaza 1 Harbour Road Wanchai, Hong Kong K3, . The official website for the company is www.sinobiopharm.com. The company can be reached via phone at 852-2802-9886, via email at stephentse@sino-biopharm.com, or via fax at 852-2880-0847. This page (OTCMKTS:SBMFF) was last updated on 9/23/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sino Biopharmaceutical Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.